Member Info for optimist13

I see Acuity's year end is the 31st March. It would be helpful to get some sort of idea on the growth in the business has been over the last financial year. From information that has been released on contract wins over the period, I bet the growth is quite significant.

https://www.investegate.co.uk/samarkand-group-plc--smk-/eqs/samarkand-group-plc---queen-s-award-for-enterprise--outstanding-contribution-to-international-trade/20220421070025EGYIW/

Letter to shareholders and potential investors:

https://mcusercontent.com/344ebd20cb9b642b7e7439bbb/files/331bd62c-d50e-1592-525a-ad7e77dfbea8/Eagle_Mountain_Mining_Letter_to_Shareholders.pdf

Our CEO, Tim Mason onsite with CEO of US Operations, Manuel Ramos, enthusiastic about the recommissioning of the underground mine and the underground drilling to come

https://twitter.com/eagle_mining/status/1514056111565021185

Steady buying over the listing price with some chunky trades. Gunsynd now sitting with over a 100% profit on their initial investment.

https://twitter.com/roguebaronuk/status/1512412442978140163

Beverage Hunters will commence distributing to the on-trade and off-trade markets from May 2022 across Spain. The agreement relates to the current award winning Shinju, the Shinju 8 year aged expression due for imminent release and the Shinju 12 and 15 year old expressions.

https://twitter.com/roguebaronuk/status/1512057604540968966

"Following the agreement with Oak and Still, the UK is expected to make up an increasing and significant proportion of Shinju’s revenues.

Rogue Baron expects to be able to announce further distribution deals in both Europe and the USA in Q2, 2022."

All sounding very positive...

It will be interesting to see the level of demand for First Tin shares when they list tomorrow. Assuming they reach a decent premium on the 30p offer price, this will represent a good paper profit on the 834k shares Gunsynd hold.

You must have missed this announcement as well:
Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company"), a UK based international pharmaceutical company trading on the Aquis Stock Exchange and focused on the treatment of various cancer conditions using its proprietary medical cannabis formulations, is pleased to announce it is advancing an application to join the OTCQB Market ("OTCQB") in the United States. Apollon's Ordinary Shares will continue to trade on the Aquis Stock Exchange under the symbol APOL.

The Company decided to undertake this application for a second trading platform for its shares at the request of several US based investors and believes that cross trading on the OTCQB will provide enhanced investor benefits, including easier access for potential investors in North America, increased trading hours and improved trading liquidity.



Apollon is also pleased to announce that it is exploring other possible up-listing options on local and international exchanges to increase investor access. The Company will maintain its existing AQSE listing, in addition to any additional up-listing it may undertake.



The Company believes that, due to the growth it has seen both in terms of the build out of its facilities and the increase in patient enquiries, moving to a more well-established exchange will provide easier trading access for institutional investors and improve liquidity for all shareholders.

Well....52.72% of the shares are held by the directors and the last placing was at 5.00p, so I don't think it will take very long to move the price up once revenue enhancing news lands.

https://www.investegate.co.uk/marketsandmarkets-/gnw/cybersecurity-market-expected-to-be-worth--345.4-billion-by-2026---exclusive-report-by-marketsandmarkets--8482-/20220405143000H6595/

Extract:

Northbrook, IL , April 05, 2022 (GLOBE NEWSWIRE) -- According to a new market research report "Cybersecurity Market with Covid-19 Impact Analysis by Component (Software, Hardware, and Services), Software (IAM, Encryption, APT, Firewall), Security Type, Deployment Mode, Organization Size, Vertical, and Region - Global Forecast to 2026" published by MarketsandMarkets™, the global cybersecurity market size is projected to grow from USD 217.9 Billion in 2021 to USD 345.4 Billion by 2026, recording a Compound Annual Growth Rate (CAGR) of 9.7% from 2021 to 2026. The market’s growth can be attributed to the increasing awareness and rising investments in cybersecurity infrastructure across global organizations operating across verticals.

Download Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=505

Decent buy on Aquis today:

05.04.22 | 12:22:33 1190476 0.84

And another:

https://www.investegate.co.uk/rogue-baron-plc--shnj-/prn/spanish-distribution-deal/20220405104223PE785/

https://www.investegate.co.uk/rogue-baron-plc--shnj-/prn/uk-distribution-deal/20220405070000PE2FA/

https://www.investegate.co.uk/rogue-baron-plc--shnj-/prn/spanish-distribution-deal/20220405104223PE785/

https://www.investegate.co.uk/rogue-baron-plc--shnj-/prn/uk-distribution-deal/20220405070000PE2FA/

Up 16% to 0.83 AUD...

First Tin IPO priced at 30p which represents a 100% increase on our original investment. will be interesting to see what the demand is for the shares next week.

https://www.investegate.co.uk/rogue-baron-plc--shnj-/prn/shinju--official-spirit-of-bloomaroo-festival/20220330130911P7817/

Interim report out:

https://www.investegate.co.uk/kcr-residential-reit--kcr-/rns/interim-results/202203300900025677G/

The "Option Period" expires on the third anniversary of Admission, which makes it the 11 July 2022.

https://www.investegate.co.uk/kcr-residential-reit--kcr-/rns/subscription-and-strategic-agreement/201907121624304368F/

If Torchlight exercise their remaining 36m options, this would take them over the 75% holding and then allow them to do whatever they want with the company.

Either way, I expect we will have some closure by then, but I suspect Torchlight will have to make an offer to buy out the remaining shareholders if they exercise their remaining options.